Overview
Urofacial syndrome (UFS), also known as Ochoa syndrome, is a rare autosomal recessive disorder characterized by the combination of a severe lower urinary tract dysfunction and an abnormal facial expression. The condition was first described by Colombian physician Bernardo Ochoa in 1987. The hallmark facial feature is an inverted or grimacing expression when attempting to smile or laugh — the face appears as though the individual is crying or in distress when they are actually expressing happiness. This distinctive facial expression is caused by abnormal co-contraction of facial muscles. The urinary tract dysfunction in urofacial syndrome involves detrusor-sphincter dyssynergia, where the bladder muscle and the urethral sphincter contract simultaneously rather than in a coordinated fashion. This leads to incomplete bladder emptying, urinary incontinence, recurrent urinary tract infections, vesicoureteral reflux, and hydronephrosis. If left untreated, the progressive urinary obstruction can result in severe kidney damage and end-stage renal failure, which is the most serious complication of the condition. Constipation and fecal soiling may also occur due to similar dyscoordination affecting bowel function. Urofacial syndrome is caused by pathogenic variants in the HPSE2 gene (UFS1, on chromosome 10q24) or the LRIG2 gene (UFS2, on chromosome 1p13). These genes are involved in neural development and signaling pathways important for proper innervation of the bladder and facial muscles. Treatment is primarily supportive and focuses on preserving kidney function. Management includes clean intermittent catheterization to ensure complete bladder emptying, prophylactic antibiotics to prevent urinary tract infections, anticholinergic medications to reduce bladder overactivity, and in some cases surgical interventions such as vesicostomy or bladder augmentation. Early diagnosis and aggressive urological management are critical to preventing irreversible renal damage.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Urofacial syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Urofacial syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Urofacial syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Urofacial syndrome.
Community
No community posts yet. Be the first to share your experience with Urofacial syndrome.
Start the conversation →Latest news about Urofacial syndrome
No recent news articles for Urofacial syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Urofacial syndrome
What is Urofacial syndrome?
Urofacial syndrome (UFS), also known as Ochoa syndrome, is a rare autosomal recessive disorder characterized by the combination of a severe lower urinary tract dysfunction and an abnormal facial expression. The condition was first described by Colombian physician Bernardo Ochoa in 1987. The hallmark facial feature is an inverted or grimacing expression when attempting to smile or laugh — the face appears as though the individual is crying or in distress when they are actually expressing happiness. This distinctive facial expression is caused by abnormal co-contraction of facial muscles. The u
How is Urofacial syndrome inherited?
Urofacial syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Urofacial syndrome typically begin?
Typical onset of Urofacial syndrome is childhood. Age of onset can vary across affected individuals.